VELGRAFT

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameVELGRAFT
Drug Alias NameVELGRAFT
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsGranulomaDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAyu Inc
China Registration ClassN/A

Develop Information

Active CompaniesAyu Inc
Inactive CompaniesN/A
Active IndicationsGranulomaDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A